A Prediction Nomogram for Moderate-to-Severe Bronchopulmonary Dysplasia in Chinese Very Preterm Infants With Respiratory Distress: A Multi‑Center Prospective Study.
Chenhong Wang, Zheng Chen, Guannan Bai, Lizhong Du, Yuan Shi, Liping Shi
{"title":"A Prediction Nomogram for Moderate-to-Severe Bronchopulmonary Dysplasia in Chinese Very Preterm Infants With Respiratory Distress: A Multi‑Center Prospective Study.","authors":"Chenhong Wang, Zheng Chen, Guannan Bai, Lizhong Du, Yuan Shi, Liping Shi","doi":"10.1002/bab.2718","DOIUrl":null,"url":null,"abstract":"<p><p>Moderate-to-severe bronchopulmonary dysplasia (msBPD) is a prevalent and severe condition in very preterm infants, contributing to long-term respiratory issues. Developing a predictive model specific to the Chinese population could support early intervention. This research focused on determining risk factors and developing a predictive model for msBPD in very preterm infants with respiratory distress, following the 2018 National Institute of Child Health and Human Development criteria. A prospective multicenter study was conducted across 26 tertiary neonatal intensive care units (NICUs) in China from March 2020 to March 2022. Infants born at < 32 weeks' gestation, admitted within 72 h of birth with a respiratory score ≥ 5, were enrolled. Infants were assigned at random to either a training cohort (800 infants from 18 NICUs) or an external validation cohort (397 infants from 8 NICUs). Predictive factors were identified using multivariate logistic regression and Lasso regression, leading to the development of a prediction nomogram. Key independent predictors included birth weight, surfactant use, early pulmonary hypertension, duration of invasive mechanical ventilation, and necrotizing enterocolitis (Stages II-III). The model demonstrated high accuracy in the training cohort (AUC = 0.844) with good calibration (Hosmer-Lemeshow test, p = 0.247). Independent validation showed consistent discrimination (AUC = 0.849) and calibration (Hosmer-Lemeshow test, p = 0.333), while decision curve analysis confirmed clinical benefit. The developed nomogram-based model offers reliable early msBPD risk assessment in very preterm infants, supporting timely clinical interventions within Chinese NICUs.</p>","PeriodicalId":9274,"journal":{"name":"Biotechnology and applied biochemistry","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology and applied biochemistry","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1002/bab.2718","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Moderate-to-severe bronchopulmonary dysplasia (msBPD) is a prevalent and severe condition in very preterm infants, contributing to long-term respiratory issues. Developing a predictive model specific to the Chinese population could support early intervention. This research focused on determining risk factors and developing a predictive model for msBPD in very preterm infants with respiratory distress, following the 2018 National Institute of Child Health and Human Development criteria. A prospective multicenter study was conducted across 26 tertiary neonatal intensive care units (NICUs) in China from March 2020 to March 2022. Infants born at < 32 weeks' gestation, admitted within 72 h of birth with a respiratory score ≥ 5, were enrolled. Infants were assigned at random to either a training cohort (800 infants from 18 NICUs) or an external validation cohort (397 infants from 8 NICUs). Predictive factors were identified using multivariate logistic regression and Lasso regression, leading to the development of a prediction nomogram. Key independent predictors included birth weight, surfactant use, early pulmonary hypertension, duration of invasive mechanical ventilation, and necrotizing enterocolitis (Stages II-III). The model demonstrated high accuracy in the training cohort (AUC = 0.844) with good calibration (Hosmer-Lemeshow test, p = 0.247). Independent validation showed consistent discrimination (AUC = 0.849) and calibration (Hosmer-Lemeshow test, p = 0.333), while decision curve analysis confirmed clinical benefit. The developed nomogram-based model offers reliable early msBPD risk assessment in very preterm infants, supporting timely clinical interventions within Chinese NICUs.
期刊介绍:
Published since 1979, Biotechnology and Applied Biochemistry is dedicated to the rapid publication of high quality, significant research at the interface between life sciences and their technological exploitation.
The Editors will consider papers for publication based on their novelty and impact as well as their contribution to the advancement of medical biotechnology and industrial biotechnology, covering cutting-edge research in synthetic biology, systems biology, metabolic engineering, bioengineering, biomaterials, biosensing, and nano-biotechnology.